LINEBURG


<< . .

 15
( 30)



. . >>

Table V.7 Perinatal complications of IVF pregnancies associated with severe
OHSS in 68 patients compared with all IVF pregnancies (international data)
Reproduced with permission from Abramov et al. (1998). Fertil Steril 70:1070À6

Number of patients with indicated complication

Perinatal complication Severe OHSS (%) All IVF (%)

Preterm PROM* 12 (17.7) 4.9
Pregnancy induced hypertension 9 (13.2) 6.0
Gestational diabetes 4 (5.9) 0.8
Oligohydramnios 3 (4.4) NA**
Placental abruption 3 (4.4) 0.4
Discordant twins 1 (1.5) NA
Intrauterine growth retardation 1 (1.5) 7.0
Chorioamnioitis 1 (1.5) NA
Stillbirth 1 (1.5) 0.7
Thromboembolic phenomena 1 (1.5) NA

* PROM ¼ premature rupture of the fetal membranes
** NA ¼ not available


prematurity and low birth weight rates are signi¬cantly higher than those
reported previously for pregnancies after assisted conception (Table V.7).


REFERENCES

Aboulghar MA, Mansour RT, Serour GI et al. (1998). Moderate ovarian hyperstimulation
syndrome complicated by deep cerebrovascular thrombosis. Hum Reprod
13:2088À91.
Abramov Y, Elchalal U & Schenker JG (1998a). Febrile morbidity in severe and
critical ovarian hyperstimulation syndrome: a multicentre study. Hum Reprod
13:3128À31.
Abramov Y, Elchalal U & Schenker JG (1998b). Obstetric outcome of in-vitro fertilized
pregnancies complicated by severe ovarian hyperstimulation syndrome: a multicenter
study. Fertil Steril 70:1070À6.
Abramov Y, Elchalal U & Schenker JG (1999a). Pulmonary manifestations of severe
ovarian hyperstimulation syndrome: a multicenter study. Fertil Steril 71:645À51.
Abramov Y, Naparstek Y, Elchalal U et al. (1999b). Plasma immunoglobulins in patients
with severe ovarian hyperstimulation syndrome. Fertil Steril 71:102À5.
Akdemir R, Uyan C & Emiroglu Y (2002). Acute myocardial infarction secondary
thrombosis associated with ovarial hyperstimulation syndrome. Int J Cardiol
83:187À9.
Andrejevic S, Bonaci-Nikolic B, Bukilica M et al. (2002). Intracardiac thrombosis and
fever possibly triggered by ovulation induction in a patient with antiphospholipid
antibodies. Scand J Rheumatol 31:249À51.
Arikan G, Giuliani A, Gucer F et al. (1997). Rare manifestations of the ovarian
hyperstimulation syndrome: a report of two cases. Clin Exp Obstet Gynecol 24:154À6.
113
REFERENCES




Aune B, Hoie KE, Oian P et al. (1991). Does ovarian stimulation for in-vitro fertilization
induce a hypercoagulable state? Hum Reprod 6:925À7.
Aurousseau MH, Samama MM, Belhassen A et al. (1995). Risk of thromboembolism
in relation to an in-vitro fertilization programme: three case reports. Hum Reprod
10:94À7.
Balasch J, Carmona F, Llach J et al. (1990). Acute prerenal failure and liver dysfunction in
a patient with severe ovarian hyperstimulation syndrome. Hum Reprod 5:3448À51.
Balasch J, Reverter JC, Fabregues F et al. (1996). Increased induced monocyte tissue factor
expression by plasma from patients with severe ovarian hyperstimulation syndrome.
Fertil Steril 66:608À13.
Bassil S, DaCosta S, Toussaint Demylle D et al. (1996). A unilateral hydrothorax as the
only manifestation of ovarian hyperstimulation syndrome: a case report. Fertil Steril
66:1023À5.
Beerendonk CC, Van Dop PA, Braat DD et al. (1998). Ovarian hyperstimulation
syndrome: facts and fallacies. Obstet Gynecol Surv 53:439À49.
Belaen B, Geerinckx K, Vergauwe P & Thys J (2001). Internal jugular vein thrombosis after
ovarian stimulation. Hum Reprod 16:510À12.
Beni¬‚a JL, Conard J, Naouri M et al. (1994). Ovarian hyperstimulation syndrome and
thrombosis. Apropos of a case of thrombosis of the internal jugular vein. Review of
the literature. J Gynecol Obstet Biol Reprod (Paris) 23:778À83.
Benshushan A, Shushan A, Palitiel O et al. (1995). Ovulation induction with clomiphene
citrate complicated by deep vein thrombosis. Eur J Obstet Gynecol Reprod Biol
62:261À2.
Bergh T & Lundkvist O (1992). Clinical complications during in-vitro fertilization
treatment. Hum Reprod 7:625À6.
´ `
Boulieu D, Ninet J, Pinede L et al. (1989). Thrombose veineuse precoce de siege
´
inhabituel, en debut de grossesse apres hyperstimulation ovarienne. Contracept Fertil
Sex 17:725À7.
Brinsden P & Rizk B (1992). The obstetric outcome of assisted conception treatment.
Assisted Reproduction Reviews 2:16À25.
Brinsden PR, Wada J, Tan SL et al. (1995). Diagnosis, prevention and management of
ovarian hyperstimulation syndrome. Br J Ostet Gynaecol 102:767À72.
Chen CD, Wu MY, Chen HF et al. (2000). Relationships of serum pro-in¬‚ammatory
cytokines and vascular endothelial growth factor with liver dysfunction in severe
ovarian hyperstimulation syndrome. Hum Reprod 15:66À71.
Choktanasiri W & Rojanasakul A (1995). Acute arterial thrombosis after gamete
intrafallopian transfer: a case report. J Assist Reprod Genet 12:335À7.
Cordani S, Bancalari L, Maggiani R et al. (2002). Massive unilateral hydrothorax as the
only clinical manifestation of ovarian hyperstimulation syndrome. Monaldi Arch
Chest Dis 57:314À17.
Cluroe AD & Synek BJ (1995). A fatal case of ovarian hyperstimulation syndrome with
cerebral infarction. Pathology 27:344À6.
Colby TV (1999). Benign mesothelial cells in lymph node. Adv Anat Pathol 6:41À8.
Dalrymple JC, Smith DH, Sinosich MJ et al. (1982À3). Venous thrombosis with high
estradiol levels following gonadotrophin therapy. Infertility 5:239À45.
Daniel Y, Yaron Y, Oren M et al. (1995). Ovarian hyperstimulation syndrome manifests as
acute unilateral hydrothorax. Hum Reprod 10:1684À5.
Davis AJ, Pandher GK, Masson GM et al. (2002). A severe case of ovarian
hyperstimulation syndrome with liver dysfunction and malnutrition. Eur J
Gastroenterol Hepatol 14:779À82.
Delvigne A (2004). Epidemiology and pathophysiology of ovarian hyperstimulation
syndrome. In (Gerris J, Olivennes F, de Sutter P, Eds), Assisted Reproductive
Technologies: Quality and Safety. New York: Parthenon Publishing, Chapter 12,
pp. 149À62.
114 COMPLICATIONS OF OVARIAN HYPERSTIMULATION SYNDROME




Delvigne A & Rozenberg S (2003). Review of clinical course and treatment of ovarian
hyperstimulation syndrome (OHSS). Hum Reprod Update 9:77À96.
Delvigne A, Demoulin A, Smitz J et al. (1993). The ovarian hyperstimulation syndrome in
in-vitro fertilization: a Belgian multicenter study. I. Clinical and biological features.
Hum Reprod 8:1353À60.
Delvigne A, Kostyla K, DeLeener A et al. (2002). Metabolic characteristics of
OHSS patients who developed ovarian hyperstimulation syndrome. Hum Reprod
17:1994À6.
Dulitzky M, Cohen SB, Inbal A et al. (2000). Increased prevalence of thrombophilia
among women with severe ovarian hyperstimulation syndrome. Fertil Steril
77:463À7.
Dumont M, Combet A & Domenichini Y (1980). Cerebral arterial thrombosis
following ovarian hyperstimulation and sextuplet pregnancy. Nouv Presse Med
13:3628À9.
Elford K, Leader A, Wee R & Stys PK (2002). Stroke in ovarian hyperstimula-
tion syndrome in early pregnancy treated with intra-arterial rt-PA. Neurology
59:1270À2.
Elter K, Scoccia B & Nelson LR (2001). Hepatic dysfunction associated with moderate
ovarian hyperstimulation syndrome: a case report. J Reprod Med 46:765À8.
Esteban-Altirriba J (1961). Le syndrome d™hyperstimulation massive des ovaries. Rev
´
Francaise de Gynecologie et d™Obstetrique 7À8:555À64.
¸
Fabregues F, Balasch J, Gines P et al. (1999). Ascites and liver test abnormalities during
severe ovarian hyperstimulation syndrome. Am J Gastroenterol 94:994À9.
Fabregues F, Tassies D, Reverter JC et al. (2004). Prevalence of thrombophilia in women
with severe ovarian hyperstimulation syndrome and cost-effectiveness of screening.
Fertil Steril 81:989À95.
Figueroa-Casas P (1958). Reaccion ovariaa monstruosa a las gonadotrophines a proposito
de un caso fatal. Ann Cirug 23:116À18.
Foong LC, Bhagavath B, Kumar J & Ng SC (2002). Ovarian hyperstimulation syndrome is
associated with reversible impairment of vascular reactivity. Fertil Steril 78:1159À63.
Forman RG, Frydman R, Egan D et al. (1990). Severe ovarian hyperstimulation
synodrome using agonists of gonadotropin-releasing hormone for in vitro fertili-
zation: a European series and a proposal for prevention. Fertil Steril 53:502À9.
Friedler S, Rachstein A, Bukovsky I et al. (1998). Unilateral hydrothorax as a sole and
recurrent manifestation of ovarian hyperstimulation syndrome following in-vitro
fertilization. Hum Reprod 13:859À61.
Fujimoto A, Osuga Y, Yano T et al. (2002). Ovarian hyperstimulation syndrome
complicated by peritonitis due to perforated appendicitis: case report. Hum Reprod
17:966À7.
Germond M, Wirthner D, Thorin D et al. (1996). Aorto-subclavian thromboembolism:
a rare complication associated with moderate ovarian hyperstimulation syndrome.
Hum Reprod 11:1173À6.
Gore L, Nawar MG, Rezk Y et al. (2002). Resistant unilateral hydrothorax as the sole
manifestation of ovarian hyperstimulation syndrome. Middle East Fertility Society
Journal 7:149À53.
Gregory WT & Patton PE (1999). Isolated pleural effusion in severe ovarian
hyperstimulation: a case report. Am J Obstet Gynecol 180:1468À71.
Hollemaert S, Wautrecht JC, Capel P et al. (1996). Thrombosis associated with ovarian
hyperstimulation syndrome in a carrier of the factor V Leiden mutation. Thromb
Haemost 76:275À7.
Horstkamp B, Lubke M, Kentenich H et al. (1994). Internal jugular vein thrombosis
caused by resistance to activated protein C as complication of ovarian hyperstimula-
tion after in-vitro fertilization. Hum Reprod 11:280À2.
115
REFERENCES




Jewelewicz R & Van de Wiele RL (1975). Acute hydrothorax as the only symptom of
ovarian hyperstimulation syndrome. Am J Obstet Gynecol 121:1121À2.
Kaaja R, Sieberg R, Titinen A et al. (1989). Severe ovarian hyperstimulation syndrome and
deep venous thrombosis. Lancet 2:1043À4.
Khalaf Y, Elkington N, Anderson H et al. (2000). Ovarian hyperstimulation syndrome and
its effect on renal function in a renal transplant patient undergoing IVF treatment:
case report. Hum Reprod 15:1275À7.
Kim HC, Kemmann E, Shelden R et al. (1981). Response of blood coagulation parameters
to elevated endogenous 17b-estradiol levels induced by human menopausal
gonadotropin. Am J Obstet Gynecol 140:807À10.
Kingsland C, Collins JV, Rizk B & Mason B (1989). Ovarian hyperstimulation presenting
as acute hydrothorax after in-vitro fertilization. Am J Obstet Gynecol 16:381À2.
Kligman I, Noyes N, Benadiva CA & Rosenwaks Z (1995). Massive deep vein thrombosis
in a patient with antithrombin III de¬ciency undergoing ovarian stimulation for in
vitro fertilization. Fertil Steril 63:673À6.
Kodama H, Fukuda J, Karube H et al. (1996). Status of the coagulation and ¬brionolytic
systems in ovarian hyperstimulation syndrome. Fertil Steril 66:417À24.
Kodama H, Takeda S, Fukuda J et al. (1997). Activation of plasma kinin system correlated
with severe coagulation disorders in patients with ovarian hyperstimulation
syndrome. Hum Reprod 12:891À5.
Lamon D, Chang CK, Hruska L et al. (2000). Superior vena cava thrombosis after in-vitro
fertilization: case report and review of the literature. Ann Vasc Surg 14:283À5.
Lesny P, Maguiness SD, Hay DM et al. (1999). Ovarian hyperstimulation syndrome and
benign intracranial hypertension in pregnancy after in-vitro fertilization and embryo
transfer: case report. Hum Reprod 14:1953À5.
Loret de Mola JR (1999). Pathophysiology of unilateral pleural effusions in the ovarian
hyperstimulation syndrome. Hum Reprod 14:272À3.
Loret de Mola JR, Kiwi R, Austin C & Goldfarb JM (2000). Subclavian deep vein
thrombosis associated with the use of recombinant follicle-stimulating hormone
(Gonal-F) complicating mild ovarian hyperstimulation syndrome. Fertil Steril
73:1253À6.
Lox C, Dorsett J, Canez M et al. (1995). Hyperoestrogenism induced by menotropins
alone or in conjunction with leuprolide acetate in in vitro fertilization cycles: the
impact on homeostasis. Fertil Steril 63:566À70.
Ludwig M, Tolg R, Richardt G et al. (1999). Myocardial infarction associated with ovarian
hyperstimulation syndrome. JAMA 282:632À3.
Lunenfeld B (1963). Treatment of anovulation by human gonadotrophins. J Int Fed
Gynecol Obstet 1:153À8.
Man A, Schwarz Y & Greif J (1997). Pleural effusion as a presenting symptom of ovarian
hyperstimulation syndrome. Eur Resp J 10:2425À6.
Mathur RS & Jenkins JM (2000). Is ovarian hyperstimulation syndrome associated with a
poor obstetric outcome? Int J Obstet Gynaecol. 107:943À6.
Mancini A, Milardi D, Di Pietro ML et al. (2001). A case of forearm amputation
after ovarian stimulation for in-vitro fertilization-embryo transfer. Fertil Steril
76:198À200.
Mathur RS, Akande AV, Keay SD et al. (2000). Distinction between early and late ovarian
hyperstimulation syndrome. Fertil Steril 73:901À7.
McGowan BM, Kay LA & Perry DJ (2003). Deep vein thrombosis followed by internal
jugular vein thrombosis as a complication of in-vitro fertilization in a woman
heterozygous for the prothrombin 3UTR and factor V Leiden mutations. Am J
Hematol 73:276À8.
Midgley DY, Khalaf Y, Braude PR et al. (1999). Recurrent cholestasis following ovarian
hyperstimulation syndrome. Hum Reprod 14:2249À51.
116 COMPLICATIONS OF OVARIAN HYPERSTIMULATION SYNDROME




Mills MS, Eddowes HA, Fox R et al. (1992). Subclavian vein thrombosis; a late
complication of ovarian hyperstimulation syndrome. Hum Reprod 7:370À1.
Mozes M, Bogowsky H, Anteby E et al. (1965). Thrombo-embolic phenomena after
ovarian stimulation with human menopausal gonadotrophins. Lancet 2:1213À15.
Nakauchi-Tanaka T, Sohda S, Someya K et al. (2003). Acquired haemophilia due to factor
VIII inhibitors in ovarian hyperstimulation syndrome: case report. Hum Reprod
18:506À8.
Neau JP, Marechaud M, Guitton P et al. (1989). Occlusion of the middle cerebral
artery after induction of ovulation with gonadotrophins. Rev Neurol (Paris)
145:859À61.
Ong ACM, Eisen V, Rennie DP et al. (1991). The pathogenesis of the ovarian
hyperstimulation syndrome (OHS): a possible role of ovarian renin. Clin Endocrinol
34:43À9.
Ou YC, Kao YL, Lai SL et al. (2003). Thromboembolism after ovarian stimulation:
successful management of a woman with superior sagittal sinus thrombosis after IVF
and embryo transfer: case report. Hum Reprod 18:2375À81.
Phillips LL, Glanstone W & Van de Wiele R (1975). Studies of the coagulation and
¬brinolytic systems in hyperstimulation syndrome after administration of human
gonadotrophin. J Reprod Med 14:138À43.
Rabinerson D, Shalev J, Royburt M et al. (2000). Severe unilateral hydrothorax as the only
manifestation of the ovarian hyperstimulation syndrome. Gynecol Obstet Invest
49:140À2.
Raziel A, Friedler S, Schachter M et al. (2002). Increased early pregnancy loss in IVF
patients with severe ovarian hyperstimulation syndrome. Hum Reprod 17:107À10.
Rizk B (1992). Ovarian hyperstimulation syndrome. In (Brinsden PR, Rainsbury PA, Eds),
A Textbook of In-vitro Fertilization and Assisted Reproduction. Carnforth, UK:
Parthenon Publishing, Chapter 23, pp. 369À84.
Rizk B (1993a). Prevention of ovarian hyperstimulation syndrome: the Ten
Commandments. Presented at the 1993 European Society of Human Reproduction
and Embryology Symposium, Tel Aviv, Israel, 1À2.
Rizk B (1993b). Ovarian hyperstimulation syndrome. In (Studd J, Ed.), Progress in
Obstetrics and Gynecology. Edinburgh: Churchill Livingstone, Chapter 18, Vol. 11,
pp. 311À49.
Rizk B (2001). Ovarian hyperstimulation syndrome: prediction, prevention and
management. In (Rizk B, Devroey P, Meldrum DR, Eds), Advances and
Controversies in Ovulation Induction. 34th ASRM Annual Postgraduate Program,
Middle East Fertility Society Pre-Congress Course. ASRM, 57th Annual Meeting,
Orlando, FL, pp. 23À46.
Rizk B (2002). Can OHSS in ART be eliminated? In (Rizk B, Meldrum D, Schoolcraft W,
Eds), A Clinical Step-by-Step Course for Assisted Reproductive Technologies. 35th
ASRM Annual Postgraduate Program, Middle East Fertility Society Pre-Congress
Course. ASRM, 58th Annual Meeting, Seattle, WA, pp. 65À102.
Rizk B & Aboulghar M (1991). Modern management of ovarian hyperstimulation
syndrome. Hum Reprod 6:1082À7.
Rizk B & Nawar MG (2001). Laparoscopic ovarian drilling for surgical induction of
ovulation in polycystic ovarian syndrome. In (Allahbadia G, Ed.), Manual of
Ovulation Induction. Mumbai, India: Rotunda Medical Technologies, Chapter 18,
pp. 140À4.
Rizk B, & Nawar MG (2004). Ovarian hyperstimulation syndrome. In (Serhal P,
Overton C, Eds), Good Clinical Practice in Assisted Reproduction. Cambridge, UK:
Cambridge University Press, Chapter 8, pp. 146À6.
Rizk B, Meagher S & Fisher AM (1990). Ovarian hyperstimulation syndrome and
cerebrovascular accidents. Hum Reprod 5:697À8.
117
REFERENCES




Rizk B, Aboulghar MA, Mansour RT et al. (1991a). Severe ovarian hyperstimulation
syndrome: analytical study of twenty-one cases. Proceedings of the VII World
Congress on In-vitro Fertilization and Assisted Procreations, Paris, Hum Reprod, 5:
pp. 368À9.
Rizk B, Tan SL, Morcos S et al. (1991b). Heterotopic pregnancies after in-vitro
fertilizations and embryo transfer. Am J Obstet Gynecol 164:161À4.
Rizk B, Doyle P, Tan SL et al. (1991c). Perinatal outcome and congenital malformations in
in-vitro fertilization babies from the Bourn Hallam Group. Hum Reprod 6:1259À64.
Rizk B & Aboulghar MA (2005). Classi¬cation, pathophysiology and management of
ovarian hyperstimulation syndrome. In (Brinsden P, Ed.), A Textbook of In-vitro
Fertilization and Assisted Reproduction, Third Edition. London: Parthenon Publishing,
Chapter 12, pp. 217À58.
Roden S, Juvin K, Homasson JP et al. (2000). An uncommon etiology of isolated pleural
effusion. The ovarian hyperstimulation syndrome. Chest 118:256À8.
Roest J, Mous H, Zeilmaker G et al. (1996). The incidence of major clinical complications
in a Dutch transport IVF programme. Hum Reprod Update 2:345À53.
Ryley NG, Froman R, Barlow D et al. (1990). Liver abnormality in ovarian
hyperstimulation syndrome. Hum Reprod 5:938À43.
Ryo E, Hagino D, Yano N et al. (1999). A case of ovarian hyperstimulation syndrome in
which antithrombin III de¬ciency occurred because of its loss into ascites. Fertil Steril
71:860À2.
Samuel MJ & Grosskinsky CM (2004). Abnormal human chorionic gonadotropin levels
and normal pregnancy outcomes in the ovarian hyperstimulation syndrome. J Reprod
Med 49:8À12.
Schanzer A, Rockman CB, Jacobowits GR et al. (2000). Internal jugular vein thrombosis in
association with the ovarian hyperstimulation syndrome. J Vasc Surg 31:815À18.
Schenker JG (1999). Clinical aspects of ovarian hyperstimulation syndrome. Eur J Obstet
Gynecol Reprod Biol 85:13À20.
Schenker JG & Ezra Y (1994). Complications of assisted reproductive techniques. Fertil
Steril 62:658À64.
Schenker JG & Weinstein D (1978). Ovarian hyperstimulation syndrome: a current
survey. Fertil Steril 30:255À68.
Semba S, Moriya T, Youssef EM et al. (2000). An autopsy case of ovarian hyperstimulation
syndrome with massive pulmonary edema and pleural effusion. Pathol Int
50:549À52.
Serour GI, Aboulghar M, Mansour R et al. (1998). Complications of medically assisted
conception in 3,500 cycles. Fertil Steril 70:638À42.
Shan Tang O, Ng E, Wai Cheng P et al. (2000). Cortical vein thrombosis misinterpreted as
intracranial hemorrhage in severe ovarian hyperstimulation syndrome. Hum Reprod
15:1913À16.
Southgate HJ, Anderson SK, Lavies NG et al. (1999). Pseudocholinesterase de¬ciency: a
dangerous unrecognized complication of the ovarian hyperstimulation syndrome.
Ann Clin Biochem 36:256À8.
Stewart JA, Hamilton PJ & Murdoch AP (1997a). Upper limb thrombosis associated with
assisted conception treatment. Hum Reprod 12:2174À5.
Stewart JA, Hamilton PJ & Murdoch AP (1997b). Thromboembolic disease associated
with ovarian and assisted conception techniques. Hum Reprod 12:2167À73.
Sueldo CE, Price HM, Bachenberg K et al. (1988). Transient liver function test
abnormalities of ovarian hyperstimulation syndrome: a case report. J Reprod Med
33:387À90.
Tan SL, Doyle P, Campbell S et al. (1992). Obstetric outcome of in-vitro fertilization
pregnancies compared to naturally conceived pregnancies. Am J Obstet and Gynecol
167:778À84.
118 COMPLICATIONS OF OVARIAN HYPERSTIMULATION SYNDROME




Thill B, Rathat C, Akula A et al. (1994). Accidents thrombo-emboliques lors des
´ ´
fecondations in vitro. Ann Fr Anesth Reanim 13:726À9.
Todorow S, Schricker ST, Siebzinruebl ER et al. (1993). Von Willebrand factor: an
endothelial marker to monitor in vitro fertilization patients with ovaran hyper-
stimulation syndrome. Hum Reprod 8:2039À49.
Todros T, Carmazzi CM, Bontempo S et al. (1999). Spontaneous ovarian hyperstimula-
tion syndrome and deep vein thrombosis in pregnancy: case report. Hum Reprod
14:2245À8.
Turkistani IM, Ghourab SA, Al-Sheikh OH et al. (2001). Central retinal artery occlu-
sion associated with severe ovarian hyperstimulation syndrome. Eur J Opthalmol
11:313À15.
Uhler ML, Budinger GR, Gabram SG & Zinaman J (2001). Perforated duodenal ulcer
associated with ovarian hyperstimulation syndrome: case report. Hum Reprod
16:174À6.
Ulug U, Aksoy E & Erden H (2003). Bilateral internal jugular venous thrombosis
following successful assisted conception in the absence of ovarian hyperstimulation
syndrome. Eur J Obstet Gynecol Reprod Biol 109:231À3.
Van der Weiden RMF, Meijers CJH & Hegt VN (2005). Ectopic mesothelial cell
proliferation in cervical lymph nodes after severe ovarian hyperstimulation
syndrome. Fertil Steril 83:739À41.
Venn A, Hemminki E, Watson L et al. (2001). Mortality in a cohort of IVF patients. Hum
Reprod 16:2691À6.
Wood N, Edozien L & Lieberman B (1998). Symptomatic unilateral pleural effusion
as a presentation of ovarian hyperstimulation syndrome. Hum Reprod 13:571À2.
Yoshii F, Ooki N, Shinohara Y et al. (1999). Multiple cerebral infarctions associated with
ovarian hyperstimulation. Neurology 53:225À7.
Younis JS, Zeevi D, Rabinowitz R et al. (1988). Transient liver function test abnormalities
of ovarian hyperstimulation syndrome. Fertil Steril 50:176À8.
Zosmer A, Katz Z, Lancet M et al. (1987). Adult respiratory distress syndrome com-
plicating ovarian hyperstimulation syndrome. Fertil Steril 47:524À6.
VI

PREDICTION OF OVARIAN
HYPERSTIMULATION SYNDROME


PREDICTION OF OVARIAN HYPERSTIMULATION
SYNDROME

The ¬rst priority in the management of ovarian hyperstimulation syndrome
is precise prediction and active prevention (Rizk, 1992, 1993). An accurate and
detailed history in addition to experienced ultrasound monitoring and
endocrine evaluation (Rizk, 2001, 2002) are the cornerstones of a successful
prediction and prevention program (Figure VI.1).


<< . .

 15
( 30)



. . >>

Copyright Design by: Sunlight webdesign